Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial.

Morley KC, Luquin N, Baillie A, Fraser I, Trent RJ, Dore G, Phung N, Haber PS.

Addiction. 2018 Dec;113(12):2205-2213. doi: 10.1111/add.14373. Epub 2018 Jul 24.

PMID:
29968397
2.

The severity of hereditary porphyria is modulated by the porphyrin exporter and Lan antigen ABCB6.

Fukuda Y, Cheong PL, Lynch J, Brighton C, Frase S, Kargas V, Rampersaud E, Wang Y, Sankaran VG, Yu B, Ney PA, Weiss MJ, Vogel P, Bond PJ, Ford RC, Trent RJ, Schuetz JD.

Nat Commun. 2016 Aug 10;7:12353. doi: 10.1038/ncomms12353.

3.

Somatic DNA mutation analysis in targeted therapy of solid tumours.

Yu B, O'Toole SA, Trent RJ.

Transl Pediatr. 2015 Apr;4(2):125-38. doi: 10.3978/j.issn.2224-4336.2015.04.04. Review.

4.

Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.

Hinchcliffe M, Le H, Fimmel A, Molloy L, Freeman L, Sullivan D, Trent RJ.

Pathology. 2014 Jan;46(1):60-8. doi: 10.1097/PAT.0000000000000026.

PMID:
24300713
5.

Can ALS-associated C9orf72 repeat expansions be diagnosed on a blood DNA test alone?

Pamphlett R, Cheong PL, Trent RJ, Yu B.

PLoS One. 2013 Jul 19;8(7):e70007. doi: 10.1371/journal.pone.0070007. Print 2013.

6.

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.

Cooper WA, Yu B, Yip PY, Ng CC, Lum T, Farzin M, Trent RJ, Mercorella B, Clarkson A, Kohonen-Corish MR, Horvath LG, Kench JG, McCaughan B, Gill AJ, O'Toole SA.

J Clin Pathol. 2013 Sep;66(9):744-8. doi: 10.1136/jclinpath-2013-201607. Epub 2013 Jun 11.

PMID:
23757037
7.

Direct-to-consumer genetic testing - clinical considerations.

Trent RJ.

Med J Aust. 2013 May 20;198(9):496-8. No abstract available.

PMID:
23682894
8.

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.

Ramos EM, Latourelle JC, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Gellera C, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Gusella JF, Lee JM, Alonso I, Sequeiros J, Myers RH, Macdonald ME.

Neurogenetics. 2013 Nov;14(3-4):173-9. doi: 10.1007/s10048-013-0364-y. Epub 2013 May 4.

9.

Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.

Trent RJ, Cheong PL, Chua EW, Kennedy MA.

Pathology. 2013 Jun;45(4):357-70. doi: 10.1097/PAT.0b013e328360b66e. Review.

PMID:
23594690
10.

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

Yip PY, Yu B, Cooper WA, Selinger CI, Ng CC, Kennedy CW, Kohonen-Corish MR, McCaughan BC, Trent RJ, Boyer MJ, Kench JG, Horvath LG, O'Toole SA.

J Thorac Oncol. 2013 Apr;8(4):408-14. doi: 10.1097/JTO.0b013e318283558e.

11.

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.

Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Marder K, Gusella JF, Lee JM, Alonso I, Sequeiros J, Myers RH, Macdonald ME.

Hum Genet. 2012 Dec;131(12):1833-40. doi: 10.1007/s00439-012-1205-z. Epub 2012 Jul 25.

12.

TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.

Lee JH, Lee JM, Ramos EM, Gillis T, Mysore JS, Kishikawa S, Hadzi T, Hendricks AE, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Gellera C, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Landwehrmeyer GB; Registry Study of the European Huntington's Disease Network, Shoulson I; Huntington Study Group COHORT project, Myers RH, MacDonald ME, Gusella JF.

Biochem Biophys Res Commun. 2012 Aug 3;424(3):404-8. Epub 2012 Jul 3.

13.

Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study.

Pamphlett R, Cheong PL, Trent RJ, Yu B.

Neuroreport. 2012 Jun 20;23(9):556-9. doi: 10.1097/WNR.0b013e3283544718.

PMID:
22564974
14.

Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.

Lee JM, Gillis T, Mysore JS, Ramos EM, Myers RH, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Griguoli A, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, MacDonald ME, Gusella JF.

Am J Hum Genet. 2012 Mar 9;90(3):434-44. doi: 10.1016/j.ajhg.2012.01.005. Epub 2012 Mar 1.

15.

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS; PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY study of the European Huntington's Disease Network, Myers RH; HD-MAPS Study Group, MacDonald ME, Gusella JF; COHORT study of the HSG.

Neurology. 2012 Mar 6;78(10):690-5. doi: 10.1212/WNL.0b013e318249f683. Epub 2012 Feb 8.

16.

Demographic history of Oceania inferred from genome-wide data.

Wollstein A, Lao O, Becker C, Brauer S, Trent RJ, Nürnberg P, Stoneking M, Kayser M.

Curr Biol. 2010 Nov 23;20(22):1983-92. doi: 10.1016/j.cub.2010.10.040. Epub 2010 Nov 11.

17.

DHPLC can be used to detect low-level mutations in amyotrophic lateral sclerosis.

Luquin N, Yu B, Trent RJ, Pamphlett R.

Amyotroph Lateral Scler. 2010;11(1-2):76-82. doi: 10.3109/17482960802572699.

PMID:
20184515
18.

Swine flu: false-positive rapid flu swab with resulting misdiagnosis of a case of Legionella pneumonia.

Schofield R, Trent RJ.

BMJ Case Rep. 2010 Aug 13;2010. pii: bcr1220092519. doi: 10.1136/bcr.12.2009.2519.

19.

Pathology practice and pharmacogenomics.

Trent RJ.

Pharmacogenomics. 2010 Jan;11(1):105-11. doi: 10.2217/pgs.09.150. Review.

PMID:
20017676
20.

A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis.

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):418-29. doi: 10.3109/17482960802635397.

PMID:
19922134
21.

Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A.

J Immunol. 2009 Nov 1;183(9):5442-8. No abstract available.

22.

The future of genetic research in exercise science and sports medicine.

Trent RJ, Yu B.

Med Sport Sci. 2009;54:187-195. doi: 10.1159/000235705. Epub 2009 Aug 17.

PMID:
19696516
23.

Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis.

Luquin N, Yu B, Saunderson RB, Trent RJ, Pamphlett R.

Neuromuscul Disord. 2009 Oct;19(10):696-700. doi: 10.1016/j.nmd.2009.07.005. Epub 2009 Aug 19.

PMID:
19695877
24.

An analysis of the entire SOD1 gene in sporadic ALS.

Luquin N, Yu B, Trent RJ, Morahan JM, Pamphlett R.

Neuromuscul Disord. 2008 Jul;18(7):545-52. doi: 10.1016/j.nmd.2008.04.013. Epub 2008 May 27.

PMID:
18504130
25.

Computer-assisted reading of DNA sequences.

Le H, Hinchcliffe M, Yu B, Trent RJ.

Methods Mol Med. 2008;141:177-97.

PMID:
18453090
26.

The impact of the Austronesian expansion: evidence from mtDNA and Y chromosome diversity in the Admiralty Islands of Melanesia.

Kayser M, Choi Y, van Oven M, Mona S, Brauer S, Trent RJ, Suarkia D, Schiefenhövel W, Stoneking M.

Mol Biol Evol. 2008 Jul;25(7):1362-74. doi: 10.1093/molbev/msn078. Epub 2008 Apr 3.

PMID:
18390477
27.

Genome-wide analysis indicates more Asian than Melanesian ancestry of Polynesians.

Kayser M, Lao O, Saar K, Brauer S, Wang X, Nürnberg P, Trent RJ, Stoneking M.

Am J Hum Genet. 2008 Jan;82(1):194-8. doi: 10.1016/j.ajhg.2007.09.010.

28.

A comparison of the lengths of androgen receptor triplet repeats in brain and blood in motor neuron diseases.

Saunderson RB, Yu B, Trent RJ, Pamphlett R.

J Neurol Sci. 2008 Apr 15;267(1-2):125-8. Epub 2007 Nov 13.

PMID:
17997416
29.

Low yield in screening patients with sporadic motor neuron disease for Kennedy disease.

Saunderson RB, Yu B, Trent RJ, Pamphlett R.

Intern Med J. 2007 Nov;37(11):772-4.

PMID:
17908088
30.

Genetic susceptibility to environmental toxicants in ALS.

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):885-90.

PMID:
17503480
31.

Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing.

Trent RJ, Webster B, Bowden DK, Gilbert A, Holl PJ, Lindeman R, Lammi A, Rowell J, Hinchcliffe M, Colley A, Wilson M, Saleh M, Blackwell J, Petrou V.

Pathology. 2006 Dec;38(6):507-19. Review.

PMID:
17393977
32.

Are enteroviral receptors different in sporadic motor neuron disease?

Saunderson RB, Yu B, Trent RJ, Pamphlett R.

Amyotroph Lateral Scler. 2007 Feb;8(1):26-30.

PMID:
17364432
33.

Identification of a candidate genetic variant for the high prevalence of type II diabetes in Polynesians.

Myles S, Hradetzky E, Engelken J, Lao O, Nürnberg P, Trent RJ, Wang X, Kayser M, Stoneking M.

Eur J Hum Genet. 2007 May;15(5):584-9. Epub 2007 Feb 28.

34.

A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Neurotoxicology. 2007 May;28(3):532-40. Epub 2006 Nov 26.

PMID:
17204329
35.

Are metallothionein genes silenced in ALS?

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Toxicol Lett. 2007 Jan 10;168(1):83-7. Epub 2006 Nov 15.

PMID:
17156946
36.

Melanesian and Asian origins of Polynesians: mtDNA and Y chromosome gradients across the Pacific.

Kayser M, Brauer S, Cordaux R, Casto A, Lao O, Zhivotovsky LA, Moyse-Faurie C, Rutledge RB, Schiefenhoevel W, Gil D, Lin AA, Underhill PA, Oefner PJ, Trent RJ, Stoneking M.

Mol Biol Evol. 2006 Nov;23(11):2234-44. Epub 2006 Aug 21.

PMID:
16923821
37.

Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study.

Li JL, Hayden MR, Warby SC, Durr A, Morrison PJ, Nance M, Ross CA, Margolis RL, Rosenblatt A, Squitieri F, Frati L, Gómez-Tortosa E, García CA, Suchowersky O, Klimek ML, Trent RJ, McCusker E, Novelletto A, Frontali M, Paulsen JS, Jones R, Ashizawa T, Lazzarini A, Wheeler VC, Prakash R, Xu G, Djoussé L, Mysore JS, Gillis T, Hakky M, Cupples LA, Saint-Hilaire MH, Cha JH, Hersch SM, Penney JB, Harrison MB, Perlman SL, Zanko A, Abramson RK, Lechich AJ, Duckett A, Marder K, Conneally PM, Gusella JF, MacDonald ME, Myers RH.

BMC Med Genet. 2006 Aug 17;7:71.

38.

Diagnosis of the haemoglobinopathies.

Trent RJ.

Clin Biochem Rev. 2006 Feb;27(1):27-38.

39.
40.

Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma.

Kohonen-Corish MR, Cooper WA, Saab J, Thompson JF, Trent RJ, Millward MJ.

J Invest Dermatol. 2006 Jan;126(1):167-71.

41.

Gene therapy in sport.

Trent RJ, Alexander IE.

Br J Sports Med. 2006 Jan;40(1):4-5. No abstract available.

42.

The EPAS1 gene influences the aerobic-anaerobic contribution in elite endurance athletes.

Henderson J, Withford-Cave JM, Duffy DL, Cole SJ, Sawyer NA, Gulbin JP, Hahn A, Trent RJ, Yu B.

Hum Genet. 2005 Dec;118(3-4):416-23. Epub 2005 Oct 6.

PMID:
16208515
43.

Screening the metallothionein III gene in sporadic amyotrophic lateral sclerosis.

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Jun;6(2):115-7.

PMID:
16036436
44.
45.

Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.

Yu B, Sawyer NA, Caramins M, Yuan ZG, Saunderson RB, Pamphlett R, Richmond DR, Jeremy RW, Trent RJ.

J Clin Pathol. 2005 May;58(5):479-85.

46.

Low microsatellite instability is associated with poor prognosis in stage C colon cancer.

Kohonen-Corish MR, Daniel JJ, Chan C, Lin BP, Kwun SY, Dent OF, Dhillon VS, Trent RJ, Chapuis PH, Bokey EL.

J Clin Oncol. 2005 Apr 1;23(10):2318-24.

PMID:
15800322
47.

Molecular characterisation of neonatal cardiac hypertrophy and its regression.

Gopinath B, Trent RJ, Yu B.

Cardiol Young. 2004 Oct;14(5):498-505.

PMID:
15680071
48.

Gene therapy: applications and progress towards the clinic.

Trent RJ, Alexander IE.

Intern Med J. 2004 Nov;34(11):621-5. Review.

PMID:
15546456
49.

Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.

Yousef ZR, Tandy SC, Tudor V, Jishi F, Trent RJ, Watson DK, Cowell RP.

Heart. 2004 Nov;90(11):1259-62.

50.

Supplemental Content

Loading ...
Support Center